InspireMD receives FDA approval for CGuard Prime TransCarotid Stent System
InspireMD announced that the FDA has approved its PMA supplement for the CGuard Prime TransCarotid Stent System, a significant regulatory milestone that expands the company's treatment options for carotid artery disease.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed